Trending...
- T&S Communications at the 25th China International Optoelectronic Exposition (CIOE)
- Dr Joy Dental Clinic Recognized as a Superbrand for 2024
- Horion M6APro Series IFPs Achieves Google EDLA Certification
Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care
NEWTON, Mass. - WisconsinEagle -- National Brain Tumor Society (NBTS), a leader in brain tumor patient advocacy, research, information, and support, today announced the launch of two interrelated public health campaigns focused on patient awareness and access to advanced biomarker testing and clinical trials.
"While continued investment and concerted drug development efforts are certainly needed, the precision medicine era has arrived for patients with brain tumors," said David Arons, president and chief executive officer of NBTS. "With the World Health Organization's two recent reclassifications of central nervous system tumors in 2016 and 2021, patients with brain tumors need more precise diagnoses. These recent advances in the understanding of the molecular characteristics of tumor types, as well as new drug approvals and encouraging results from recent clinical trials, call for a greater understanding of patient options from the point of diagnosis. We want to ensure that brain tumors undergo comprehensive biomarker analysis and that patients and their care partners better understand and have improved access to clinical trials and expanded access options that might be their best source of care. To achieve this result, the NBTS campaigns will inform patients, seek improved coverage from insurers, and work with providers."
More on Wisconsin Eagle
NBTS is launching the campaigns based on data on educational gaps in the brain tumor community gathered via a broad survey. Data collection analysis will inform future strategies, in addition to already planned educational and engagement activities.
The campaigns are being launched and developed with the generous support from Bayer, Danaher Foundation, and Servier Pharmaceuticals.
About the National Brain Tumor Society
Building on over 30 years of experience, the National Brain Tumor Society (NBTS) unrelentingly invests in, mobilizes, and unites the brain tumor community to discover a cure, deliver effective treatments, and advocate for patients and caregivers. Our focus on defeating brain tumors and improving the quality of patients' lives is powered by our partnerships across science, healthcare, policy, and business sectors. We fund treatments-focused research and convene those most critical to curing brain tumors once and for all. Join us at BrainTumor.org.
"While continued investment and concerted drug development efforts are certainly needed, the precision medicine era has arrived for patients with brain tumors," said David Arons, president and chief executive officer of NBTS. "With the World Health Organization's two recent reclassifications of central nervous system tumors in 2016 and 2021, patients with brain tumors need more precise diagnoses. These recent advances in the understanding of the molecular characteristics of tumor types, as well as new drug approvals and encouraging results from recent clinical trials, call for a greater understanding of patient options from the point of diagnosis. We want to ensure that brain tumors undergo comprehensive biomarker analysis and that patients and their care partners better understand and have improved access to clinical trials and expanded access options that might be their best source of care. To achieve this result, the NBTS campaigns will inform patients, seek improved coverage from insurers, and work with providers."
More on Wisconsin Eagle
- BTR: Understanding the Critical 2FA Vulnerability in QR Code Enrollment Processes Uncovered by Silent Sector – Lauro Chavez
- "I Spy" Challenge for Manufacturing Month
- The Queens of Milwaukee Tours Launches Inaugural Tour
- IGC Pharma Wins 2 Awards in Phase 1 of NIA's AI PREPARE Challenge, Advancing Alzheimer's Early Prediction Research
- Get in the Halloween Spirit at Rare Books LA Union Station
NBTS is launching the campaigns based on data on educational gaps in the brain tumor community gathered via a broad survey. Data collection analysis will inform future strategies, in addition to already planned educational and engagement activities.
The campaigns are being launched and developed with the generous support from Bayer, Danaher Foundation, and Servier Pharmaceuticals.
About the National Brain Tumor Society
Building on over 30 years of experience, the National Brain Tumor Society (NBTS) unrelentingly invests in, mobilizes, and unites the brain tumor community to discover a cure, deliver effective treatments, and advocate for patients and caregivers. Our focus on defeating brain tumors and improving the quality of patients' lives is powered by our partnerships across science, healthcare, policy, and business sectors. We fund treatments-focused research and convene those most critical to curing brain tumors once and for all. Join us at BrainTumor.org.
Source: National Brain Tumor Society
0 Comments
Latest on Wisconsin Eagle
- And The Winner Is: Special Request Ft Rey T (AKA) Reynard Thomas
- Allegiant Management Group Launches New Website Following Recent Rebranding
- Celebrating 30 Years: 2024 Diversity Visa Lottery Opens Oct. 2, Offering Life-Changing Opportunities for U.S. Immigration
- Quidax Launches $125,000 Crypto Innovation Pitch, Partners with Moonshot for TC Battlefield
- Wagoner Roofing Launches New Website
- L-Strategies LLC terminates Angie Wong Miami Republican Committeewoman's contract with New Federal State of China NFSC
- Sara Abbas Excites Global Listeners With Much-Anticipated Viral Release Of New Single "Love You From A Distance"
- Horion M6APro Series IFPs Achieves Google EDLA Certification
- How to Get a Handicap Placard in California: Simplifying the Process for Disabled Drivers HandicapMD.com Offers Easy Online Certification for Disabled
- Use Bitcoin to Earn Bitcoin - Innovative Layer 2 Solution for Bitcoin
- Dr Joy Dental Clinic Recognized as a Superbrand for 2024
- T&S Communications at the 25th China International Optoelectronic Exposition (CIOE)
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New Doctor of Behavioral Health Graduates
- Local Provider Roadrunner Health Services Outperforms Corporate Competitors in New Mexico's Correctional Facilities
- Non Profit Organization "The Breast Cancer Fundraiser" Prepares for Breast Cancer Awareness Month
- Leading Arizona Real Estate Team Rebrands to SPACE, Marking a New Era in Real Estate Innovation
- Office Calgary Inc has Partnered with RingCentral to provide Telecommunications Systems
- Aquia Inc. Wins 5-Year $15-Million USPTO Continuous Authorization to Operate (cATO) Contract
- Trade Meter AI Featured on StartUpers Podcast's Pilot Episode: A Deep Dive into the Future of AI-Powered Stock Analysis
- E.G. Phillips Cinematic Single a Fiery Rebuke to Election Season Chaos Agents